Search Results - "Kasli, I."
-
1
HPR151 Has Project Orbis Facilitated Faster Access to Oncology Therapies in Great Britain Following 'Brexit'?
Published in Value in health (01-12-2022)Get full text
Journal Article -
2
HTA32 Does a Major Added Benefit From the G-Ba Correspond to Positive Outcomes Across Major Markets? An Analysis Based on the Prismaccess Database
Published in Value in health (01-12-2022)Get full text
Journal Article -
3
PBI70 WILL CAR-T CELL THERAPIES CHANGE HOW DRUGS ARE PRICED AND REIMBURSED?
Published in Value in health (01-11-2019)Get full text
Journal Article -
4
PCN196 WILL CAR-T CELL THERAPIES CHANGE HOW DRUGS ARE PRICED AND REIMBURSED?
Published in Value in health (01-05-2019)Get full text
Journal Article -
5
PNS139 Single Arm Trials: Route to Success Despite Increasing Demands for Evidence – an Analysis Based on the Prismaccess Database
Published in Value in health (01-12-2020)Get full text
Journal Article -
6
PRO106 A NEW MAJOR MARKET ACCESS CHALLENGE - KEEPING THE ROI WINDOW OPEN?
Published in Value in health (01-11-2019)Get full text
Journal Article -
7
PHP85 - THE RISE OF THE NON-SUBMISSION – A WORRYING TREND FOR UK PATIENT ACCESS WITH ‘BREXIT’ APPROACHING
Published in Value in health (01-10-2018)Get full text
Journal Article -
8
PNS206 AIM FOR THE STARS, REACH THE MOON? A SIMPLE STRATEGY TO IMPROVE ADDITIONAL BENEFIT OUCTOMES IN GERMANY?
Published in Value in health (01-11-2019)Get full text
Journal Article -
9
PRS48 UNLOCKING THE ACCESS CHALLENGES TO COPD
Published in Value in health (01-11-2019)Get full text
Journal Article -
10
PCN230 - ARE NICE AND THE SMC DIVERGING IN THEIR ASSESSMENT OF ONCOLOGY DRUGS?
Published in Value in health (01-10-2018)Get full text
Journal Article -
11